SCHEMBL14143457

SCHEMBL14143457

CCCC(NCl)C(O)C(=O)NC1CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.40
SMYD3 Q9H7B4 1/20 0.38
GPR88 Q9GZN0 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
KDM1A O60341 1/20 0.34
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
LMNA P02545 1/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13075251 1.00 KMT2A (0.40) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL8279021 1.00 KMT2A (0.40) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL8280179 0.91 SIGMAR1 (0.42) KMT2ASMYD3SIGMAR1HPGDMAPT
SCHEMBL10316135 0.85 SMYD3 (0.39) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL13075362 0.85 SMYD3 (0.39) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL8279479 0.85 SMYD3 (0.39) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL13219667 0.84 SMYD3 (0.38) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL3719801 0.83 SMN1; SMN2 (0.38) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL3729020 0.83 SMN1; SMN2 (0.38) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1
SCHEMBL13201859 0.83 SMYD3 (0.37) KMT2ASMYD3GPR88SMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7399749-B2 Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-15 US disclosed